OPALIA PHARMA
OPALIA PHARMA S.A., a contractor and subcontractor, manufactures medicinal products. It offers medicinal products in various forms, including liquid shapes for external and internal use; creams, ointments, and gels; and suppositories and pessaries. The company also provides various services, which comprise development, purchase of components, regulatory follow-up, and pharmaceutical release services; and galenical and analytical development services, such as pre-formulation, formulation, primary packaging, pharmaco-technical tests, analytical development, experimental batches manufacturing, and CTD writing services
OPALIA PHARMA
Industry:
Biotechnology Manufacturing
Founded:
1988-01-01
Address:
Ariana, Tunis, Tunisia
Country:
Tunisia
Website Url:
http://www.opaliapharma.com.tn
Status:
Active
Contact:
216 70 55 90 64
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Google Maps Contact Form 7 WooCommerce ThemePunch WooCommerce Add To Cart WPML Multilingual
Similar Organizations
Microdermis
Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.
National Science Foundation
America’s Seed Fund at the National Science Foundation awards nearly $200 million annually to startups and small businesses.
Current Employees Featured
Founder
Official Site Inspections
http://www.opaliapharma.com.tn Semrush global rank: 9.1 M Semrush visits lastest month: 214
- Host name: 196.203.251.4
- IP address: 196.203.251.4
- Location: Tunisia
- Latitude: 34
- Longitude: 9
- Timezone: Africa/Tunis
More informations about "Opalia Pharma"
Opalia recordati
OPALIA PHARMA was created in 1988 with the main aim of being able to provide access to health care and medicines for the poorest people with exceptional ... Our history. Our articles. …See details»
25/06/2023, 18:48 recordati.com/public/pub.aspx?id=125
90% of the share capital of Opalia Pharma S.A.. In Oct ober 2013, following permission received from the Tunisian anti-trust authorities, 67% of the share capital of Opalia Pharma. S.A. held …See details»
RECORDATI ACQUIRES THE TUNISIAN PHARMACEUTICAL …
Jul 24, 2013 Opalia Pharma was established in 1988, ranks eighth in the Tunisian pharmaceutical market and is the third largest local pharmaceutical company. The company …See details»
RECORDATI FINALIZES THE FIRST TRANCHE OF ITS ACQUISITION …
Oct 31, 2013 Opalia Pharma was established in 1988, ranks eighth in the Tunisian pharmaceutical market and is the third largest local pharmaceutical company. The company …See details»
Opalia Tunisia - PharmaBoardroom
Jul 11, 2017 Opalia, founded in 1988 by Alya El Hedda and Marco Montanari is a Tunisian generics and OTC products developer and manufacturer. A pioneer and national leader, it was acquired by the Italian multinational Recordati in …See details»
OPALIA PHARMA Company Profile - Dun & Bradstreet
OPALIA PHARMA. Website. Get a D&B Hoovers Free Trial. Overview Company Description:? Industry: Nonclassifiable establishments. Printer Friendly View Address: ZONE …See details»
Recordati acquires Tunisia's Opalia - PharmaTimes
Jul 25, 2013 Recordati is buying a 90% stake in Opalia Pharma of Tunisia in a deal valued at 80 million dinar, or around 37 million euros. Opalia, which is headquartered in Ariana, a suburb of …See details»
OPALIA RECORDATI : 35 ans d’Engagement envers la …
Sep 22, 2023 Depuis 2013, le Groupe RECORDATI a fait son entrée avec l’acquisition de 90% du capital d’OPALIA Pharma, devenant ainsi OPALIA RECORDATI, sa filiale en Tunisie et la seule en Afrique. Fondée en 1926 et …See details»
OPALIA Pharma - PitchBook
OPALIA Pharma was founded in 1988. Where is OPALIA Pharma headquartered? OPALIA Pharma is headquartered in Ariana, Tunisia. What is the size of OPALIA Pharma? OPALIA Pharma has 400 total employees. What …See details»
Recordati acquires Tunisian pharmaceutical company Opalia Pharma
Jul 24, 2013 Opalia Pharma, established in 1988, markets branded generic drugs with leading products in dermatology and in the gastrointestinal and respiratory therapeutic areas. The firm …See details»
Opalia Pharma - Products, Competitors, Financials, Employees ...
May 27, 2014 Opalia Pharma markets branded generic drugs with leading products in dermatology and in the gastrointestinal and respiratory therapeutic areas. Opalia …See details»
RECORDATI ACQUIRES THE TUNISIAN PHARMACEUTICAL …
Jul 24, 2013 Opalia Pharma was established in 1988, ranks eighth in the Tunisian pharmaceutical market and is the third largest local pharmaceutical company. The company …See details»
OPALIA PHARMA S.A. - DevelopmentAid
OPALIA PHARMA S.A. — Supplier from Tunisia, has experience with World Bank HQ, Horizon Europe (2021 - 2027), it`s involved in Health, Industry, Commerce & Services, Laboratory & …See details»
OPALIA Pharma SA: Drug pipelines, Patents, Clinical trials - Synapse
Jun 27, 2023 Explore OPALIA Pharma SA with its drug pipeline, therapeutic area, technology platform, .See details»
Recordati Acquires the Tunisian Pharmaceutical Company Opalia …
Jul 24, 2013 Opalia Pharma was established in 1988, ranks eighth in the Tunisian pharmaceutical market and is the third largest local pharmaceutical company. The company …See details»
PharmaBoardroom - Interview: Alya El Hedda - General Manager, …
Jul 11, 2017 Alya El Hedda, GM of Opalia-Recordati in Tunisia, describes the Opalia affiliate's evolution since the Recordati takeover, her ambitions for the future, and how the company will …See details»
Opalia Pharma - Contacts, Employees, Board Members
Organization. Opalia Pharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 12. About. ... Opalia …See details»
#1 Opalia Pharma / Recordati - Histoire et philosophie - Dr
Interview avec Dr. Alya El HEDDA, Directrice Générale d'Opalia Recordati, un des leaders dans l'industrie pharmaceutique en Tunisie.See details»
Recordati Eyes Growth with Opalia Pharma Acquisition
Recordati said it will acquire Opalia Pharma for TND 80 million ($48.5 million), in an effort to expand operations into the Middle East market.See details»